RESUMO
This study aimed to evaluate well-documented diagnostic antigens, named B13, 1F8 and JL7 recombinant proteins, as potential markers of seroconversion in treated chagasic patients. Prospective study, involving 203 patients treated with benznidazole, was conducted from endemic areas of northern Argentina. Follow-up was possible in 107 out of them and blood samples were taken for serology and PCR assays before and 2, 3, 6, 12, 24 and 36 months after treatment initiation. Reactivity against Trypanosoma cruzi lysate and recombinant antigens was measured by ELISA. The rate of decrease of antibody titers showed nonlinear kinetics with an abrupt drop within the first three months after initiation of treatment for all studied antigens, followed by a plateau displaying a low decay until the end of follow-up. At this point, anti-B13, anti-1F8 and anti-JL7 titers were relatively close to the cut-off line, while anti-T. cruzi antibodies still remained positive. At baseline, 60.8% (45/74) of analysed patients tested positive for parasite DNA by PCR and during the follow-up period in 34 out of 45 positive samples (75.5%) could not be detected T. cruzi DNA. Our results suggest that these antigens might be useful as early markers for monitoring antiparasitic treatment in chronic Chagas disease.
Assuntos
Anticorpos Antiprotozoários/sangue , Doença de Chagas/tratamento farmacológico , Nitroimidazóis/uso terapêutico , Tripanossomicidas/uso terapêutico , Adulto , Antígenos de Protozoários/imunologia , Argentina , Doença de Chagas/sangue , Doença Crônica , Estudos de Coortes , Ensaio de Imunoadsorção Enzimática , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Fatores de Tempo , Adulto JovemRESUMO
We report a case of chagasic meningoencephalitis reactivation in a pregnant woman co-infected with Trypanosoma cruzi and HIV that was successfully managed with benznidazole and highly active antiretroviral therapy. Early diagnosis enabled rapid specific treatment that improved the health of the patient and her baby.
Assuntos
Síndrome da Imunodeficiência Adquirida , Doença de Chagas/tratamento farmacológico , Encefalite/tratamento farmacológico , Nitroimidazóis/uso terapêutico , Complicações Infecciosas na Gravidez , Tripanossomicidas/uso terapêutico , Síndrome da Imunodeficiência Adquirida/tratamento farmacológico , Adulto , Terapia Antirretroviral de Alta Atividade , Coinfecção , Feminino , Humanos , Recém-Nascido , Gravidez , Resultado da Gravidez , Resultado do Tratamento , Trypanosoma cruzi/genéticaRESUMO
Corneal transplantation is the most frequent transplant worldwide. Tissue characteristics allow storage and transport, even between continents, increasing its accessibility around the world. Donor infection with Trypanosoma cruzi is not defined as a corneal discarding factor, although the transplant is not recommended preventively, as in any infectious diseases. Herein, by means of polymerase chain reaction (PCR) strategies, we analyzed parasite presence in ocular tissue from 10 deceased donors with Chagas diseases. Among them, positive findings were obtained in corneas, scleras, and eye muscle samples of three, two, and one donor, respectively. Moreover, among the six T. cruzi defined populations, TcV and TcVI parasites were found in some samples based on group-specific amplification strategies. Our findings point out the actual possibility of T. cruzi transmission due to corneal transplantation and makes donor's serological status knowledge mandatory regardless of graft provenance. Failing that, we suggest a posttransplant follow-up of recipients from seropositive donors.
Assuntos
Doença de Chagas/transmissão , Córnea/parasitologia , Músculos Oculomotores/parasitologia , Esclera/parasitologia , Trypanosoma cruzi/genética , Adulto , Idoso , Argentina , Transplante de Córnea , DNA de Protozoário/análise , Feminino , Genótipo , Humanos , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Doadores de Tecidos , Obtenção de Tecidos e ÓrgãosRESUMO
Trypanosoma cruzi lineages, microsatellite allelic polymorphism, and mithocondrial gene haplotypes were directly typified from peripheral blood and cerebrospinal fluid specimens of a Bolivian patient with Chagas disease with accompanying AIDS and central nervous system severe involvement. Of note, the patient's blood was infected by a mixture of T. cruzi I and T. cruzi IId/e polyclonal populations while the cerebrospinal fluid showed only a monoclonal T. cruzi I population. Our findings do not corroborate the original assumption of innocuity for T. cruzi I in the southern cone of the Americas and highlight lineage I tropism for central nervous system causing lethal Chagas reactivation.
Assuntos
Infecções Oportunistas Relacionadas com a AIDS/parasitologia , Síndrome da Imunodeficiência Adquirida/complicações , Infecções Protozoárias do Sistema Nervoso Central/parasitologia , Doença de Chagas/etiologia , Trypanosoma cruzi/fisiologia , Adulto , Animais , Bolívia , Sistema Nervoso Central/parasitologia , Infecções Protozoárias do Sistema Nervoso Central/diagnóstico , Infecções Protozoárias do Sistema Nervoso Central/etiologia , Doença de Chagas/parasitologia , DNA de Protozoário/sangue , DNA de Protozoário/líquido cefalorraquidiano , Complexo IV da Cadeia de Transporte de Elétrons/genética , Evolução Fatal , Humanos , Masculino , Repetições de Microssatélites/genética , Polimorfismo Genético , Polimorfismo de Fragmento de Restrição , Recidiva , Tropismo/genética , Trypanosoma cruzi/genética , Trypanosoma cruzi/isolamento & purificaçãoRESUMO
PURPOSE: Report the results obtained following the implementation of an OCC (Obstetric Critical Care) model. MATERIALS AND METHODS: This is an observational prospective study in obstetric population with high complexity illness attended in a safety and quality model of attention in a specific unit supporting the concept of obstetric critical care. Records were used as the primary source for collecting information, using the standards of the Center for Clinical Research. RESULTS: In a 5-year period, 10,956 patients were admitted. About 51% had diseases that were not exclusive to pregnancy, 91% were admitted while pregnant and, from all births, 46% were by vaginal delivery. 1685 (19%) patients met the criteria for Near Miss Maternal Mortality (NMMM). Forty-three patients died, which represented a mortality rate of 0.49% of the total of hospitalized patients. CONCLUSIONS: The implementation of an OOC model, security models, and an institutional support system improve the quality of care in the obstetric services of reference hospitals in developing countries.
Assuntos
Unidades de Terapia Intensiva/estatística & dados numéricos , Mortalidade Materna , Complicações do Trabalho de Parto/terapia , Unidade Hospitalar de Ginecologia e Obstetrícia/estatística & dados numéricos , Complicações na Gravidez/terapia , Adolescente , Adulto , Peso ao Nascer , Cesárea/estatística & dados numéricos , Criança , Colômbia/epidemiologia , Feminino , Idade Gestacional , Humanos , Recém-Nascido , Pessoa de Meia-Idade , Complicações do Trabalho de Parto/mortalidade , Gravidez , Complicações na Gravidez/epidemiologia , Cuidado Pré-Natal/métodos , Estudos Prospectivos , Melhoria de Qualidade , Adulto JovemRESUMO
BACKGROUND: We describe intraoperative and postdischarge outcomes of a case series after the prophylactic use of resuscitative endovascular balloon occlusion of the aorta (REBOA) during elective cesarean delivery in pregnant women with morbidly adherent placenta (MAP). We furthermore performed a systematic review and meta-analysis to investigate the safety and effectiveness of the use of REBOA during elective cesarean delivery in pregnant women with MAP. METHODS: Descriptive case series of REBOA (December 2015 to June 2017) used during elective cesarean delivery in pregnant women with MAP. The systematic review was conducted following PRISMA guidelines. We included studies involving pregnant women with a diagnosis of MAP who underwent an elective cesarean delivery with prophylactic REBOA placement. A meta-analysis was performed to assess the overall amount of transfusions and intraoperative hemorrhage of REBOA compared to NO-REBOA cases. RESULTS: A total of 12 patients with MAP underwent elective cesarean delivery with REBOA deployment. The median (interquartile range) of packed red blood cells transfused during the first 24 hours following surgery was two units (0-3.5). The median (interquartile range) of intraoperative blood loss was 1,500 mL (900-2,750). At 28 days, all patients were alive, and no adverse outcomes were observed. Four articles were included in the systematic review and meta-analysis. These articles included a total of 441 patients. Quantitative synthesis (meta-analysis) found that the use of REBOA as prophylaxis for the prevention of major hemorrhage was associated with a lower amount of intraoperative hemorrhage (in milliliters) (weighted mean difference, -1,384.66; 95% confidence interval, -2,141.74 to -627.58) and lower requirements of blood products transfusions (in units) (weighted mean difference, -2.42; 95% confidence interval, -3.90 to -0.94). CONCLUSION: We provide clinical data supporting the use of REBOA in the management of pregnant women with MAP undergoing elective cesarean delivery. Our findings demonstrate the feasibility of REBOA as a prophylactic intervention to improve outcomes in women at risk of catastrophic postpartum hemorrhage. LEVEL OF EVIDENCE: Therapeutic study, level V; Systematic Review, level IV.
Assuntos
Aorta Torácica/cirurgia , Oclusão com Balão/métodos , Procedimentos Endovasculares/métodos , Placentação , Complicações Cardiovasculares na Gravidez/prevenção & controle , Ressuscitação/métodos , Choque Hemorrágico/prevenção & controle , Feminino , Humanos , Gravidez , Complicações Cardiovasculares na Gravidez/etiologia , Choque Hemorrágico/etiologiaRESUMO
Congenital transmission of Trypanosoma cruzi may occur in some or all the gestations from a T. cruzi-infected mother. Variable rates of congenital transmission have been reported in different geographical areas where different parasitic strains predominate, suggesting that parasitic genotypes might play a role in the risk of congenital transmission. Moreover, in cases of transmission it is unknown if the whole maternal T. cruzi population or certain clones are preferentially transmitted by the transplacental route. In this study, bloodstream T. cruzi lineages were identified in blood samples from congenitally infected children, transmitting and non-transmitting mothers and unrelated Chagas disease patients, using improved PCR strategies targeted to nuclear genomic markers. T. cruzi IId was the prevalent genotype among 36/38 PCR-positive congenitally infected infants, 5/5 mothers who transmitted congenital Chagas disease, 12/13 mothers who delivered non-infected children and 28/34 unrelated Chagas disease patients, all coming from endemic localities of Argentina and Bolivia. These figures indicate no association between a particular genotype and vertical transmission. Furthermore, minicircle signatures from the maternal and infants' bloodstream trypanosomes were profiled by restriction fragment length polymorphism of the 330-bp PCR-amplified variable regions in seven cases of mothers and congenitally infected infants. Minicircle signatures were nearly identical between each mother and her infant/s and unique to each mother-infant/s case, a feature that was also observed in twin deliveries. Moreover, allelic size polymorphism analysis of microsatellite loci from populations transmitted to twins showed that all clones from the maternal polyclonal population were equally infective to both siblings.
Assuntos
Doença de Chagas/congênito , DNA de Protozoário/genética , Transmissão Vertical de Doenças Infecciosas/estatística & dados numéricos , Complicações Parasitárias na Gravidez/genética , Trypanosoma cruzi/genética , Adolescente , Adulto , Animais , Argentina/epidemiologia , Bolívia/epidemiologia , Doença de Chagas/epidemiologia , Doença de Chagas/transmissão , Criança , Pré-Escolar , Suscetibilidade a Doenças , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Mães , Reação em Cadeia da Polimerase , Gravidez , Fatores de RiscoRESUMO
The protozoan Trypanosoma cruzi is the etiological agent of Chagas disease. In immunosuppressed individuals, as it occurs in the coinfection with human immunodeficiency virus (HIV), the central nervous system may be affected. In this regard, reactivation of Chagas disease is severe and often lethal, and it accounts for meningoencephalitis. Astrocytes play a crucial role in the environment maintenance of healthy neurons; however, they can host HIV and T. cruzi. In this report, human astrocytes were infected in vitro with both genetically modified-pathogens to express alternative fluorophore. As evidenced by fluorescence microscopy and flow cytometry, HIV and T. cruzi coexist in the same astrocyte, likely favoring reciprocal interactions. In this context, lower rates of cell death were observed in both T. cruzi monoinfected-astrocytes and HIV-T. cruzi coinfection in comparison with those infected only with HIV. The level of HIV replication is significantly diminished under T. cruzi coinfection, but without affecting the infectivity of the HIV progeny. This interference with viral replication appears to be related to the T. cruzi multiplication rate or its increased intracellular presence but does not require their intracellular cohabitation or infected cell-to-cell contact. Among several Th1/Th2/Th17 profile-related cytokines, only IL-6 was overexpressed in HIV-T. cruzi coinfection exhibiting its cytoprotective role. This study demonstrates that T. cruzi and HIV are able to coinfect astrocytes thus altering viral replication and apoptosis.
Assuntos
Apoptose , Astrócitos/imunologia , Doença de Chagas/complicações , Coinfecção , Infecções por HIV/complicações , Replicação Viral/fisiologia , Apoptose/efeitos dos fármacos , Astrócitos/parasitologia , Astrócitos/virologia , Morte Celular , Linhagem Celular , Doença de Chagas/imunologia , Doença de Chagas/virologia , Citocinas/metabolismo , HIV/fisiologia , Infecções por HIV/imunologia , Herpesvirus Humano 2/fisiologia , Humanos , Interleucina-6 , Nitroimidazóis/farmacologia , Células Th1/imunologia , Células Th17/imunologia , Células Th2/imunologia , Trypanosoma cruzi/genética , Trypanosoma cruzi/imunologia , Trypanosoma cruzi/fisiologiaRESUMO
Disclosing virulence factors from pathogens is required to better understand the pathogenic mechanisms involved in their interaction with the host. In the case of Trypanosoma cruzi several molecules are associated with virulence. Among them, the trans-sialidase (TS) has arisen as one of particular relevance due to its effect on the immune system and involvement in the interaction/invasion of the host cells. The presence of conserved genes encoding for an inactive TS (iTS) isoform is puzzlingly restricted to the genome of parasites from the Discrete Typing Units TcII, TcV, and TcVI, which include highly virulent strains. Previous in vitro results using recombinant iTS support that this isoform could play a different or complementary pathogenic role to that of the enzymatically active protein. However, direct evidence involving iTS in in vivo pathogenesis and invasion is still lacking. Here we faced this challenge by transfecting iTS-null parasites with a recombinant gene that allowed us to follow its expression and association with pathological events. We found that iTS expression improves parasite invasion of host cells and increases their in vivo virulence for mice as shown by histopathologic findings in heart and skeletal muscle.
Assuntos
Doença de Chagas/parasitologia , Glicoproteínas/metabolismo , Neuraminidase/metabolismo , Trypanosoma cruzi/genética , Fatores de Virulência/genética , Animais , Doença de Chagas/patologia , Chlorocebus aethiops , Glicoproteínas/genética , Humanos , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C3H , Modelos Animais , Neuraminidase/genética , Cultura Primária de Células , Ratos , Ratos Sprague-Dawley , Transfecção , Trypanosoma cruzi/patogenicidade , Células Vero , Virulência/genética , Fatores de Virulência/metabolismoRESUMO
Trypanosoma cruzi DNA was amplified from an intracranial biopsy and peripheral blood of an HIV patient with encephalitis; this episode was indicative of AIDS and congenital Chagas disease. The analysis of a micro-satellite locus revealed a multiclonal parasite population at the brain lesion with a more complex minicircle signature than that profiled in blood using restriction fragment length polymorphism (RFLP)-PCR and low stringency single primer (LSSP) PCR. Interestingly, different sublineages of T. cruzi II were detected in blood and brain by means of spliced-leader and 24salpha ribosomal-DNA amplifications. Quantitative-competitive PCR monitored the decrease of parasitic load during treatment and secondary prophylaxis with benznidazole. The synergy between parasiticidal plus anti-retroviral treatments probably allowed the patient a longer survival than usually achieved in similar episodes. This is the first case report demonstrating a differential distribution of natural parasite populations and sublineages in Chagas disease reactivation, showing the proliferation of cerebral variants not detectable in peripheral blood.
Assuntos
Infecções Oportunistas Relacionadas com a AIDS/diagnóstico , Doença de Chagas/diagnóstico , Encefalite/diagnóstico , Trypanosoma cruzi/isolamento & purificação , Infecções Oportunistas Relacionadas com a AIDS/sangue , Infecções Oportunistas Relacionadas com a AIDS/complicações , Infecções Oportunistas Relacionadas com a AIDS/patologia , Adulto , Animais , Doença de Chagas/sangue , Doença de Chagas/complicações , Doença de Chagas/patologia , DNA de Cinetoplasto/análise , DNA de Protozoário/análise , Encefalite/complicações , Encefalite/patologia , Variação Genética , Humanos , Imageamento por Ressonância Magnética , Masculino , Reação em Cadeia da Polimerase , Polimorfismo de Fragmento de Restrição , Trypanosoma cruzi/classificação , Trypanosoma cruzi/genéticaRESUMO
The extent of inflammation, fibrosis, and progression of chronic Chagas heart disease (cChHD) was associated with persistence of parasite DNA in cardiac lesions of necropsies or explants from Argentinean cChHD patients. A Trypanosoma cruzi-based polymerase chain reaction showed a positive result in 1) 15% of cardiac sections with less than 10 mononuclear inflammatory cells/high-power field (440x) (MNC/HPF), 89% with 10-19 MNC/HPF, and 100% with more than 20 MNC/HPF (P < 0.0001); 2) 33% with less than 10% fibrosis, 79% with 10-19% fibrosis, and 100% with more than 20% fibrosis (P < 0.01); 3) 25% of specimens from patients classified in Kuschnir groups 0 and I, 70% in group II and 90% in group III (P < .001); and 4) 45% and 90% of the specimens from cChHD patients without or with heart failure, respectively (P < 0.01). These findings stress the role of the parasite in pathogenesis and disease progression of cChHD.
Assuntos
Cardiomiopatia Chagásica/parasitologia , DNA de Protozoário/isolamento & purificação , Coração/parasitologia , Miocárdio/patologia , Trypanosoma cruzi/isolamento & purificação , Adulto , Idoso , Animais , Argentina , Sequência de Bases , Southern Blotting , Cardiomiopatia Chagásica/mortalidade , Cardiomiopatia Chagásica/patologia , Doença Crônica , DNA de Protozoário/química , Eletroforese em Gel de Ágar , Feminino , Fibrose , Humanos , Inflamação , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , Trypanosoma cruzi/genéticaRESUMO
Trypanosoma cruzi the agent of Chagas disease is a monophyletic but heterogeneous group conformed by several Discrete Typing Units (DTUs) named TcI to TcVI characterized by genetic markers. The trans-sialidase (TS) is a virulence factor involved in cell invasion and pathogenesis that is differentially expressed in aggressive and less virulent parasite stocks. Genes encoding TS-related proteins are included in a large family divided in several groups but only one of them contains TS genes. Two closely related genes differing in a T/C transition encode the enzymatically active TS (aTS) and a lectin-like TS (iTS). We quantified the aTS/iTS genes from TcII and TcVI aggressive and TcI low virulent strains and found variable aTS number (1-32) per haploid genome. In spite of being low TS enzyme-expressers, TcI strains carry 28-32 aTS gene copies. The intriguing absence of iTS genes in TcI strains together with the presence of aTS/iTS in TcII and TcVI strains (virulent) were observed. Moreover, after sequencing aTS/iTS from 38 isolates collected along the Americas encompassing all DTUs, the persistent absence of the iTS gene in TcI, TcIII and TcIV was found. In addition, the sequence clustering together with T/C transition analysis correlated to DTUs of T. cruzi. The consistence of TS results with both evolutionary genome models proposed for T. cruzi, namely the "Two Hybridization" and the "Three Ancestor" was discussed and reviewed to fit present findings. Parasite stocks to attempt genetic KO or to assay the involvement of iTS in parasite biology and virulence are finally available.
Assuntos
Genes de Protozoários , Glicoproteínas/genética , Neuraminidase/genética , Trypanosoma cruzi/classificação , Trypanosoma cruzi/genética , Fatores de Virulência/genética , Doença de Chagas/parasitologia , Códon , Genoma de Protozoário , Dados de Sequência Molecular , Filogenia , Polimorfismo de Nucleotídeo ÚnicoRESUMO
Genotyping studies show a polarized geographic distribution of Trypanosoma cruzi lineages in humans. Here, we assessed their distribution along Latin America through an immunological approach we designated Western blot (WB) assay with Trypomastigote small-surface antigen (TSSA) I and TSSA II (TSSA-WB). These antigens are expressed by T. cruzi I (TCI; now TcI) and T. cruzi II (TCII; reclassified as TcII to TcVI) parasites. TSSA-WB showed good concordance with genotyping tests. An unexpected frequency of TSSA II recognition was observed in Colombia, Venezuela, and Mexico (northern region of Latin America). In Argentina and Paraguay (southern region), immunophenotyping confirmed the already reported TCII (TcII to TcVI) dominance. The lineage distribution between these regions showed significant difference but not among countries within them (except for Colombia and Venezuela). TSSA-WB shows TCII emergence in the northern region where TCI was reported as dominant or even as the unique T. cruzi lineage infecting humans.
Assuntos
Doença de Chagas/epidemiologia , Doença de Chagas/parasitologia , Doenças Endêmicas , Trypanosoma cruzi/classificação , Trypanosoma cruzi/imunologia , Anticorpos Antiprotozoários/sangue , Antígenos de Protozoários/genética , Antígenos de Protozoários/imunologia , Western Blotting , Genótipo , Humanos , Imunofenotipagem , América Latina/epidemiologia , Trypanosoma cruzi/genéticaRESUMO
Chagas disease ranks among the world's most neglected tropical diseases and congenital transmission is increasingly responsible for urbanization of Chagas disease in non-endemic areas. Molecular assays for amplification and profiling of parasite minicircle DNA (kDNA) and identification of discrete typing units (DTUs) were prospectively conducted in bloodstream and placental samples from pregnant women cursing chronic Chagas disease residing in Buenos Aires city. Sensitivity of kDNA-PCR increased from 75.6% to 95.6% when one to three sequential blood samples were analysed. Congenital infection (CI) was diagnosed in 3 neonates born to kDNA-PCR positive mothers, one who had transmitted CI in a previous gestation, pointing to family clustering of congenital transmission. Fourteen of 44 placental samples were kDNA-PCR positive, all from non-CI transmitting women, indicating that placental PCR is not useful for CI diagnosis. Placental PCR positivity was not related to maternal bloodstream PCR positivity and placental parasitic subpopulations not observed in bloodstream were detected by minicircle signatures. PCR targeted to intergenic regions of spliced-leader genes and serological tests using trypomastigote small surface recombinant antigens showed predominance of DTU group TcII/V/VI and only one patient infected with TcI. To our knowledge, this is the first PCR-based follow-up study of bloodstream and placental T. cruzi infections during pregnancy, including identification of DTUs. kDNA-PCR assays in serial blood samples provided high sensitivity for detection of T. cruzi DNA in pregnant women with chronic Chagas disease.
Assuntos
Doença de Chagas/epidemiologia , Doença de Chagas/transmissão , DNA de Cinetoplasto/genética , Doenças Placentárias/parasitologia , Trypanosoma cruzi/patogenicidade , Urbanização , Adulto , Argentina/epidemiologia , Western Blotting , Doença de Chagas/genética , Doença Crônica , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Recém-Nascido , Doenças Placentárias/epidemiologia , Reação em Cadeia da Polimerase , Gravidez , Complicações Parasitárias na Gravidez/epidemiologia , Complicações Parasitárias na Gravidez/genética , Estudos Prospectivos , Trypanosoma cruzi/genéticaRESUMO
This study aimed to evaluate well-documented diagnostic antigens, named B13, 1F8 and JL7 recombinant proteins, as potential markers of seroconversion in treated chagasic patients. Prospective study, involving 203 patients treated with benznidazole, was conducted from endemic areas of northern Argentina. Follow-up was possible in 107 out of them and blood samples were taken for serology and PCR assays before and 2, 3, 6, 12, 24 and 36 months after treatment initiation. Reactivity against Trypanosoma cruzi lysate and recombinant antigens was measured by ELISA. The rate of decrease of antibody titers showed nonlinear kinetics with an abrupt drop within the first three months after initiation of treatment for all studied antigens, followed by a plateau displaying a low decay until the end of follow-up. At this point, anti-B13, anti-1F8 and anti-JL7 titers were relatively close to the cut-off line, while anti-T. cruzi antibodies still remained positive. At baseline, 60.8% (45/74) of analysed patients tested positive for parasite DNA by PCR and during the follow-up period in 34 out of 45 positive samples (75.5%) could not be detected T. cruzi DNA. Our results suggest that these antigens might be useful as early markers for monitoring antiparasitic treatment in chronic Chagas disease.
Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Adulto Jovem , Anticorpos Antiprotozoários/sangue , Doença de Chagas/tratamento farmacológico , Nitroimidazóis/uso terapêutico , Tripanossomicidas/uso terapêutico , Antígenos de Protozoários/imunologia , Argentina , Doença de Chagas/sangue , Doença Crônica , Estudos de Coortes , Ensaio de Imunoadsorção Enzimática , Seguimentos , Estudos Prospectivos , Fatores de TempoRESUMO
The intergenic region of spliced-leader (SL-IR) genes from 105 Trypanosoma cruzi I (Tc I) infected biological samples, culture isolates and stocks from 11 endemic countries, from Argentina to the USA were characterised, allowing identification of 76 genotypes with 54 polymorphic sites from 123 aligned sequences. On the basis of the microsatellite motif proposed by Herrera et al. (2007) to define four haplotypes in Colombia, we could classify these genotypes into four distinct Tc I SL-IR groups, three corresponding to the former haplotypes Ia (11 genotypes), Ib (11 genotypes) and Id (35 genotypes); and one novel group, Ie (19 genotypes). Genotypes harbouring the Tc Ic motif were not detected in our study. Tc Ia was associated with domestic cycles in southern and northern South America and sylvatic cycles in Central and North America. Tc Ib was found in all transmission cycles from Colombia. Tc Id was identified in all transmission cycles from Argentina and Colombia, including Chagas cardiomyopathy patients, sylvatic Brazilian samples and human cases from French Guiana, Panama and Venezuela. Tc Ie gathered five samples from domestic Triatoma infestans from northern Argentina, nine samples from wild Mepraia spinolai and Mepraia gajardoi and two chagasic patients from Chile and one from a Bolivian patient with chagasic reactivation. Mixed infections by Tc Ia+Tc Id, Tc Ia+Tc Ie and Tc Id+Tc Ie were detected in vector faeces and isolates from human and vector samples. In addition, Tc Ia and Tc Id were identified in different tissues from a heart transplanted Chagas cardiomyopathy patient with reactivation, denoting histotropism. Trypanosoma cruzi I SL-IR genotypes from parasites infecting Triatoma gerstaeckeri and Didelphis virginiana from USA, T. infestans from Paraguay, Rhodnius nasutus and Rhodnius neglectus from Brazil and M. spinolai and M. gajardoi from Chile are to our knowledge described for the first time.
Assuntos
Doença de Chagas/parasitologia , Doença de Chagas/transmissão , DNA Intergênico , Repetições de Microssatélites , RNA Líder para Processamento , Trypanosoma cruzi/genética , Animais , Sequência de Bases , Doença de Chagas/veterinária , DNA de Protozoário/genética , Reservatórios de Doenças/parasitologia , Genótipo , Geografia , Humanos , Insetos Vetores/parasitologia , Dados de Sequência Molecular , Filogenia , Alinhamento de Sequência , Triatominae/parasitologia , Trypanosoma cruzi/classificação , Trypanosoma cruzi/isolamento & purificaçãoRESUMO
Congenital transmission of Trypanosoma cruzi was diagnosed in 2 triplets born to a triamniotic bichorionic delivery. Only the sisters sharing the placenta became infected, as diagnosed by microhematocrit and/or polymerase chain reaction of 3 parasite targets. The neonates' parasitologic response to benznidazole was monitored. Molecular strategies allowed genotyping lineage IId and identical minicircle signatures in both triplets, showing they harbored the same maternal parasite populations.
Assuntos
Doença de Chagas/tratamento farmacológico , Doença de Chagas/transmissão , Complicações Parasitárias na Gravidez/diagnóstico , Complicações Parasitárias na Gravidez/tratamento farmacológico , Trypanosoma cruzi/isolamento & purificação , Adolescente , Animais , Doença de Chagas/diagnóstico , DNA de Protozoário/química , DNA de Protozoário/genética , Feminino , Humanos , Recém-Nascido , Dados de Sequência Molecular , Nitroimidazóis/uso terapêutico , Gravidez , Análise de Sequência de DNA , Trigêmeos , Tripanossomicidas/uso terapêutico , Trypanosoma cruzi/classificação , Trypanosoma cruzi/genéticaRESUMO
OBJECTIVES: This prospective study focused on the evaluation of anti-parasitic therapy in congenital Chagas' disease, diagnosed and monitored by PCR and conventional diagnosis. MATERIALS AND METHODS: We studied 152 children born to seroreactive mothers, living in a non-endemic area. Fifty infants aged 0-6 months (GA) were diagnosed by microhaematocrit and PCR and 102 children aged 7 months to 17 years (GB) were diagnosed by serology and PCR. Forty treated patients were monitored for 2 or 3 years by PCR and conventional methods. A competitive-quantitative PCR was used to determine pre-therapy parasitic loads and follow their post-treatment evolution. RESULTS: In GA, the sensitivities of the PCR and microhaematocrit were 100% and 82.4% and their specificities 97% and 100%, respectively. In GB, the sensitivity of the PCR was 73.8% with a specificity of 100%. Pre-therapy parasitic loads ranged from 12.5 to 125,000 and 12.5 to 125 parasite genomic equivalents/mL of blood in GA and GB, respectively. PCR turned negative in all treated pre-therapy PCR positive patients before or at the end of treatment, which was followed by their seronegativation in 10/10 GA, in 3/5 children initiating therapy at 7 months to 2 years of age but in 0/16 initiating therapy at an older age. Two out of the latter patients were occasionally PCR positive during post-treatment, suggesting no parasitological response. Out of nine pre-therapy PCR negative patients, four turned seronegative after treatment, suggesting that in undetermined patients, undetectable parasitic burdens may lead to better post-treatment prognosis. CONCLUSIONS: PCR was useful for sensitive diagnosis and therapy monitoring, allowing early detection of refractory cases.
Assuntos
Antiparasitários/uso terapêutico , Doença de Chagas/diagnóstico , Doença de Chagas/tratamento farmacológico , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Adolescente , Animais , Antiparasitários/administração & dosagem , Argentina , Doença de Chagas/parasitologia , Criança , Pré-Escolar , Primers do DNA , DNA de Protozoário/biossíntese , DNA de Protozoário/genética , Etídio , Feminino , Seguimentos , Hematócrito , Humanos , Lactente , Recém-Nascido , Masculino , Monitorização Fisiológica , Estudos Prospectivos , Testes Sorológicos , Trypanosoma cruzi/genéticaRESUMO
Ocho pacientes con historia de angina de pecho fueron estudiados hemodinámicamente mediante cateterismo izquierdo siguiendo la técnica de Sones, utilizando un cateter ileono de líquido y conectado a un transductor y a un polígrafo para obtener el registro contínuo de presiones. Se realizó en todos los casos ventriculografía izquierda en proyección oblícua anterior derewcha (OAD) antes y 30 minutos después de la administración oral de 20 mg de 5-mononitrato de isosorbide (5 MNIS). Los volúmenes ventriculares en telediástole y telesístole fueron calculados usando un microcomputador y se utilizó el factor de regresión de Kennedy para el cálculo de volúmenes verdaderos, los cuales fueron ciorrelacionados con la superficie corporal del paciente. Se obtuvo además la relación Presión Final de Sístole (PFS), Volumen Final de Sístole (VFS) del Ventrículo Izq. (VI). El estudio demuestra claramente un mejoría de todos los parámetros analizados a los 30 minutos de administrado el medicamento por vía oral, señalándose una reducción estadísticamente significativa de la Presión Sistólica Aórticca (PSAo), de la Presión Final de Diástole Ventricular Izq. (Pd2 VI), de los Volúmenes Final de Diástole (VFDVI) y Sístole (VFSDI), con un aumento de la Fracción de Expulsión del VI (FE) y de la relación PFS/VFS. Tanto la Frecuencia Cardíaca (VD) como la Presión Diástolica Aórtica (PDAo) como el Volumen Latido (VL) no mostraron modificaciones significativas